Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACE-PRO: Antibiotic Prophylaxis Duration in Pacemaker Implantation
NCT06355115Phase 2Recruiting
- Sponsor
- Brawijaya University
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of cefazolin in bacterial infection, sponsored by Brawijaya University. Started Sep 2023; status: recruiting.
02
Drugs
cefazolin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT06355115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355115.